NVO

LifeMD’s inventory soars 13% as firm and Medifast to create weight-management program that features GLP-1 medication

Novo Nordisk’s Wegovy cuts danger of coronary heart assault and stroke by 20% amongst folks with out diabetes, examine finds

Why Coke, others, could also be spared, as a $100 billion alternative in weight reduction medication unfolds says JPMorgan

Novo Nordisk, now Europe’s second-largest firm by market cap, lifts outlook after 46% revenue rise

As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss medicine to $77 billion